Skip to main content
Toggle navigation
Login
Home
Back
Favorite
0
Like
Facebook
Tweet
Session VII: Emerging Treatment Approaches for Esophagogastric Cancer
Debate: Checkpoint Inhibitors as First-Line Treatment for All Patients with Gastric Cancer? Yes vs. No - NO
Friday, November 18, 2022
9:13 AM – 9:21 AM
Debate Speaker(s)
Rutika Mehta, MD, MPH (she/her/hers)
H. Lee Moffitt Cancer Center